Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Energy expenditure during allogeneic and autologous bone marrow transplantationV Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2009
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)H Ghesquières, C Ferlay, C Sebban, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)E Jantunen, C Canals, M Attal, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.Bulletin Du Cancer|September 2, 2000
[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer]B Pottecher, R Herbrecht, M P Blanc-Vincent, et al.Presse Medicale (Paris, France : 1983)|November 10, 2000
[Infection and cancer: general information and specific questions]M Viot, M P Blanc-Vincent, J Béal, et al.Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de MoelleM André, M Henry-Amar, J L Pico, et al.Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.Pageof 16